BR0016720A - Uso de trimebutina para tratamento de dores - Google Patents

Uso de trimebutina para tratamento de dores

Info

Publication number
BR0016720A
BR0016720A BR0016720-7A BR0016720A BR0016720A BR 0016720 A BR0016720 A BR 0016720A BR 0016720 A BR0016720 A BR 0016720A BR 0016720 A BR0016720 A BR 0016720A
Authority
BR
Brazil
Prior art keywords
trimebutin
treat pain
pain
treat
trimethoxybenzoate
Prior art date
Application number
BR0016720-7A
Other languages
English (en)
Inventor
Agnes Grouhel
Gilles Brunelle
Francois Roman
Jacques Hamon
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP99125756A external-priority patent/EP1110549A1/en
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0016720A publication Critical patent/BR0016720A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"USO DE TRIMEBUTINA PARA TRATAMENTO DE DORES". A presente invenção refere-se ao uso da trimebutina [maleato hidrogenado de 2-dimetilamino-2-fenilbutil-3,4,5-trimetoxibenzoato], ou seus correspondentes estereoisómeros, para a preparação de um medicamento para prevenir e/ou tratar a dor somática inflamatória, assim como, a dor crónica.
BR0016720-7A 1999-12-23 2000-12-22 Uso de trimebutina para tratamento de dores BR0016720A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99125756A EP1110549A1 (en) 1999-12-23 1999-12-23 Use of trimebutine for treating pain
PCT/EP2000/013351 WO2001047515A1 (en) 1999-12-23 2000-12-22 Use of trimebutine for treating pain

Publications (1)

Publication Number Publication Date
BR0016720A true BR0016720A (pt) 2002-09-03

Family

ID=8239707

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016720-7A BR0016720A (pt) 1999-12-23 2000-12-22 Uso de trimebutina para tratamento de dores

Country Status (7)

Country Link
US (1) US20030119903A1 (pt)
EP (1) EP1244441A1 (pt)
JP (1) JP2003518497A (pt)
BR (1) BR0016720A (pt)
CA (1) CA2394747A1 (pt)
MX (1) MXPA02006376A (pt)
SV (1) SV2001000242A (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2653869A1 (en) * 2006-06-06 2007-12-13 Antibe Therapeutics Inc. Salts of trimebutine and n-desmethyl trimebutine
FR2927076B1 (fr) * 2008-01-31 2010-03-26 Oroxcell Derives de 2-amino-2-phenyl-alkanol, leur preparation et les compositions pharmaceutiques qui les contiennent
CN102397243A (zh) * 2010-09-08 2012-04-04 杭州赛利药物研究所有限公司 马来酸曲美布汀注射剂及其制备方法
JP2021066660A (ja) * 2018-02-09 2021-04-30 アピオン・ジャパン有限会社 Ｔｉｒａｐ阻害剤
CN113171353B (zh) * 2021-04-25 2022-10-21 海南普利制药股份有限公司 一种马来酸曲美布汀片

Also Published As

Publication number Publication date
CA2394747A1 (en) 2001-07-05
MXPA02006376A (es) 2002-11-29
US20030119903A1 (en) 2003-06-26
JP2003518497A (ja) 2003-06-10
SV2001000242A (es) 2001-10-25
EP1244441A1 (en) 2002-10-02

Similar Documents

Publication Publication Date Title
MXPA02010801A (es) Agentes diagnosticos, de representacion y terapeuticos cationicos asociados con sitios vasculares activados.
IL139230A0 (en) Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds to the upper respiratory tract and/or the ear
ES2163034T3 (es) Composiciones micelares de copolimeros de bloque de polieter, para la objetivizacion de agentes biologicos como diana.
PT806941E (pt) Composicoes anti-bacterianas liposomicas de rigidez baixa
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
ES2192832T3 (es) Uso de compuestos macrolidos para tratar glaucoma.
BRPI0410049A (pt) composto ou um sal ou estereoisÈmero farmaceuticamente aceitável do mesmo, uso de um composto, composição farmacêutica, e, kit farmacêutico
WO2001076555A3 (en) Lipid-based drug delivery systems for topical application
BR0116481A (pt) Compostos de heterociclilalquilindol ou azaindol como ligandos de 5-hidroxitriptamina-6
ATE473749T1 (de) Verwendung von rhamnolipiden zur wundheilung, behandlung und vorbeugung einer zahnfleischerkrankung und periodontaler regeneration
PT946157E (pt) Utilizacao topica de agonistas kapa-opioides para o tratamento da dor ocular
BRPI0408889A (pt) uso de clusterina para o tratamento e/ou prevenção de doenças neurológicas periféricas
BR0016720A (pt) Uso de trimebutina para tratamento de dores
TR200102512T2 (tr) Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı.
DE60320034D1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
EE200100689A (et) IL6RIL6 kimääri kasutamine ravimi valmistamiseks,mis on ette nähtud neuroloogiliste haiguste ravimiseks, ning farmatseutiline kompositsioon
BR0112131A (pt) Composições farmacêuticas e métodos para uso
WO2000061231A3 (en) Medical use
BR0017340A (pt) Tratamento de trauma e outras indicações
BR0009194A (pt) Composição do resorcinol
EP1044691A3 (en) Use of glycosaminoglycan lipid conjugates for inducing osteogenesis
BR9807271A (pt) Tamoxifeno como terapia para reduzir diarréia induzida por cloridrato de irinotecano
CA2452432A1 (en) Active ingredient combination for the pharmacological therapy of nicotine dependence
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]